TNF in Melanoma Patients Treated With Immunotherapy

Trial Profile

TNF in Melanoma Patients Treated With Immunotherapy

Phase of Trial: Phase II

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
  • Indications Malignant melanoma
  • Focus Proof of concept; Therapeutic Use
  • Acronyms MELANF
  • Most Recent Events

    • 04 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top